Biogen, Inc. (BIIB)

181.55 -3.35 (-1.81%) USD  |  NASDAQ  |  Mar 13, 16:00
181.25 -0.30 (-0.17%) After-Hours: 20:00
More

Biogen EPS Diluted (TTM) : 8.806 for Dec. 31, 2025

EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for BIIB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Amgen, Inc. 14.23
Eli Lilly & Co. 22.59
Merck & Co., Inc. 7.275
AbbVie, Inc. 2.361
Pfizer Inc. 1.355